Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kirsi Talala

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
Prostate Cancer and Prostatic Diseases|January 31, 2019
Allopurinol and the risk of prostate cancer in a Finnish population-based cohortVille Kukko, Antti Kaipia, Kirsi Talala, et al.
Scandinavian Journal of Urology|September 16, 2016
Warfarin use and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate CancerPete T T Kinnunen, Teemu J Murtola, Kirsi Talala, et al.
Scientific Reports|July 10, 2018
Cancer mortality does not differ by antiarrhythmic drug use: A population-based cohort of Finnish menKalle J Kaapu, Lauri Rantaniemi, Kirsi Talala, et al.
European Journal of Cancer (Oxford, England : 1990)|April 2, 2020
Patients' education level and treatment modality for prostate cancer in the Finnish Randomized Study of Screening for Prostate CancerTuomas P Kilpeläinen, Kirsi Talala, Kimmo Taari, et al.
International Journal of Cancer|September 3, 2022
Prostate cancer incidence in men with prostate-specific antigen below 3 ng/mL: The Finnish Randomized Study of Screening for Prostate CancerIdris Olasunmbo Ola, Kirsi Talala, Teuvo Tammela, et al.
International Journal of Cancer|July 17, 2025
Risk factors for low-risk prostate cancer: A retrospective cohort study within the FinRSPC trialUzoamaka E Okwor, Jani Raitanen, Kirsi Talala, et al.
BMC Cancer|August 31, 2017
Prostate cancer-specific survival among warfarin users in the Finnish Randomized Study of Screening for Prostate CancerPete T T Kinnunen, Teemu J Murtola, Kirsi Talala, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|December 11, 2017
Prognostic factors of prostate cancer mortality in a Finnish randomized screening trialSubas Neupane, Ewout Steyerberg, Jani Raitanen, et al.
European Urology Focus|July 30, 2017
Statin Use and Prostate Cancer Survival in the Finnish Randomized Study of Screening for Prostate CancerTeemu J Murtola, Antti I Peltomaa, Kirsi Talala, et al.
Urologic Oncology|April 12, 2025
Do differences in secondary treatment explain mortality impact of prostate cancer screening? - A randomized screening trialJoona Lampela, Kirsi Talala, Teuvo L J Tammela, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Prostate Cancer and Prostatic Diseases|January 31, 2019
Allopurinol and the risk of prostate cancer in a Finnish population-based cohortVille Kukko, Antti Kaipia, Kirsi Talala, et al.
Scandinavian Journal of Urology|September 16, 2016
Warfarin use and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate CancerPete T T Kinnunen, Teemu J Murtola, Kirsi Talala, et al.
Scientific Reports|July 10, 2018
Cancer mortality does not differ by antiarrhythmic drug use: A population-based cohort of Finnish menKalle J Kaapu, Lauri Rantaniemi, Kirsi Talala, et al.
European Journal of Cancer (Oxford, England : 1990)|April 2, 2020
Patients' education level and treatment modality for prostate cancer in the Finnish Randomized Study of Screening for Prostate CancerTuomas P Kilpeläinen, Kirsi Talala, Kimmo Taari, et al.
International Journal of Cancer|September 3, 2022
Prostate cancer incidence in men with prostate-specific antigen below 3 ng/mL: The Finnish Randomized Study of Screening for Prostate CancerIdris Olasunmbo Ola, Kirsi Talala, Teuvo Tammela, et al.
International Journal of Cancer|July 17, 2025
Risk factors for low-risk prostate cancer: A retrospective cohort study within the FinRSPC trialUzoamaka E Okwor, Jani Raitanen, Kirsi Talala, et al.
BMC Cancer|August 31, 2017
Prostate cancer-specific survival among warfarin users in the Finnish Randomized Study of Screening for Prostate CancerPete T T Kinnunen, Teemu J Murtola, Kirsi Talala, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|December 11, 2017
Prognostic factors of prostate cancer mortality in a Finnish randomized screening trialSubas Neupane, Ewout Steyerberg, Jani Raitanen, et al.
European Urology Focus|July 30, 2017
Statin Use and Prostate Cancer Survival in the Finnish Randomized Study of Screening for Prostate CancerTeemu J Murtola, Antti I Peltomaa, Kirsi Talala, et al.
Urologic Oncology|April 12, 2025
Do differences in secondary treatment explain mortality impact of prostate cancer screening? - A randomized screening trialJoona Lampela, Kirsi Talala, Teuvo L J Tammela, et al.
Pageof 7